Search

Your search keyword '"Chen, Meiqin"' showing total 155 results
Start Over Author "Chen, Meiqin"
155 results on '"Chen, Meiqin"'

14. IGFBP2 from a novel copper metabolism-associated biomarker promoted glioma progression and response to immunotherapy

Author

Luo, Qisheng, primary, Zhuang, Junhong, additional, Zheng, Dandan, additional, Miao, Changfeng, additional, Luo, Hongcheng, additional, Peng, Jun, additional, Zheng, Chuanhua, additional, Qin, Chengjian, additional, Lan, Chuanliu, additional, Chen, Meiqin, additional, Xia, Ying, additional, Huang, Deyou, additional, and Chen, Zigui, additional

Published
2023
Full Text
View/download PDF

19. Hypothalamic Menin regulates systemic aging and cognitive decline

Author

Leng, Lige, primary, Yuan, Ziqi, additional, Su, Xiao, additional, Chen, Zhenlei, additional, Yang, Shangchen, additional, Chen, Meiqin, additional, Zhuang, Kai, additional, Lin, Hui, additional, Sun, Hao, additional, Li, Huifang, additional, Xue, Maoqiang, additional, Xu, Jun, additional, Yan, Jingqi, additional, Chen, Zhenyi, additional, Yuan, Tifei, additional, and Zhang, Jie, additional

Published
2023
Full Text
View/download PDF

25. The Natural History of Parapharyngeal Solitary Fibrous Tumor/Hemangiopericytoma: A Case Report.

Author

Xu, Mengyou, Chen, Meiqin, Hua, Hongzhong, Yin, Jie, and Yan, Senxiang

Subjects
*DISEASE progression, *MESENCHYME tumors, *SYMPTOMS, *NECK, *SKULL base
Abstract

Solitary fibrous tumor/hemangiopericytoma (SFT/HPC) is extremely rare, and most of them are immediately treated for radical resection. However, the information concerning its natural history remains unclear. In this report, we presented a patient with parapharyngeal SFT/HPC, who was not immediately treated with surgical resection at first diagnosis. After approximately 3 years, the tumor volume doubling time (TVDT) and specific growth rate (SGR) could be measured through 3 serial magnetic resonance imagings. The TVDTs in the early and late pretreatment stages were 350 and 180 days, respectively, while the SGRs were 0.002 and 0.003, respectively. The growth rate of this disease entity is generally slow and may accelerate in the disease process. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

29. Immobilization-assisted abdominal deep inspiration breath-hold in post-mastectomy radiotherapy of left-sided breast cancer with internal mammary chain coverage

Author

Chen, Meiqin, primary, Zang, Shoumei, additional, Yu, Hao, additional, Ning, Lihua, additional, Huang, Huijie, additional, Bu, Luyi, additional, Ge, Jia, additional, Xu, Mengyou, additional, Tang, Qiuying, additional, Zhao, Feng, additional, Yao, Guorong, additional, and Yan, Senxiang, additional

Published
2021
Full Text
View/download PDF

47. Early interventional therapy for acute massive pulmonary embolism guided by minimally invasive hemodynamic monitoring

Author

Wang, Lihua, Xu, Yi, Zhang, Weiwen, Lu, Wei, Chen, Meiqin, and Luo, Jian

Subjects
Original Article
Abstract

Aim: The aim of this study was to investigate the clinical significance of minimally invasive hemodynamic monitoring in the early catheter-based intervention for acute massive pulmonary embolism (PE). Methods: A total of 40 cases with acute massive PE were randomized into experimental and control group with 20 cases in each group. In the experimental group, the hemodynamics was monitored via Vigileo/FloTrac system, while echocardiography was used in the control group. Twelve hours after systemic thrombolysis, catheter-based clot fragmentation and local thrombolysis were employed in the experimental group if Vigileo/FloTrac system revealed hemodynamic abnormality. For the control group, the application of catheter was determined by the findings in echocardiography at 24 hours after systemic thrombolysis. Results: A total of 12 cases in the experimental group underwent catheter therapy successfully while 4 cases in the control group received the same treatment. Compared to the control group, 12 hours after catheter intervention the experimental group had higher PaO2/FIO2 and right ventricular ejection fraction (RVEF) but lower pulmonary artery systolic pressure (PASP), indicating the effectiveness of Vigileo/FloTrac monitoring. The 28-day survival rates were identical between the groups although one patent in the control group died. Both the RVEF and PASP were significantly improved in the experimental group in 6 months compared to the control group. Conclusions: In massive PE, hemodynamic monitoring via Vigileo/FloTrac system might be useful in the decision making for catheter intervention after systemic thrombolysis and might improve the outcomes for patients.

Published
2015

50. New steroidal anti-inflammatory antedrugs: Methyl 3,20-dioxo-9α-fluoro-11β,17α,21-trihydroxy-1,4-pregnadiene-16α-carboxylate and methyl 21-acetyloxy-3,20-dioxo-11β,17α-dihydroxy-9α-fluoro-1,4-pregnadiene-16α-carboxylate

Author

J.Lee Henry, Ann S. Heiman, Dong-Hoon Ko, and Chen Meiqin

Subjects
Pharmacology, medicine.medical_specialty, biology, Metabolite, medicine.medical_treatment, Organic Chemistry, Clinical Biochemistry, Biochemistry, Steroid, chemistry.chemical_compound, Endocrinology, Glucocorticoid receptor, chemistry, Internal medicine, Edema, medicine, biology.protein, Bioassay, Croton oil, Enzyme inducer, medicine.symptom, Molecular Biology, Glucocorticoid, medicine.drug
Abstract

Focused efforts have been made to increase local-to-systemic activity ratios of potent anti-inflammatory steroids for local and/or topical applications. The approach taken in the present investigation is based upon the concept of "antedrug," defined as a locally active compound that exerts its action at the application site but rapidly undergoes a predictable biotransformation to an inactive metabolite that is readily excreted upon entry into the systemic circulation. In continuing efforts to synthesize potent, anti-inflammatory steroids without systemic glucocorticoid activities, 9 alpha-fluoro-methyl 11 beta, 17 alpha, 21-trihydroxy-3,20-dioxo-pregna-1,4-diene-16 alpha-carboxylate (FP16CM) and its 21-acetate derivative (FP16CMAc) have been synthesized and screened. Novel antedrugs were evaluated for antiinflammatory activity in the acute croton oil-induced ear edema bioassay, adverse systemic effects in the 5-day croton oil model, receptor binding, and concomitant L-tyrosine-2-oxoglutarate aminotransferase (EC 2.6.1.5) (TAT) enzyme induction in HTC cells in culture. Following a single topical application in the croton oil-induced ear edema bioassay, treatment with all compounds resulted in dose-dependent inhibition of edema. From these dose-response profiles, the following ID50 values (nmol resulting in a 50% reduction of edema) were calculated: 817, 540, 266, and 67 for hydrocortisone (HC), prednisolone (P), FP16CM, and FP16CMAc, respectively. Calculated relative potencies, setting HC = 1.0, were P, 1.5; FP16CM, 3.1, and FP16CMAc, 12.2. Results of the 5-day rat croton oil ear edema bioassay indicated that, in contrast to the parent compound P, the novel steroidal antedrugs did not significantly alter body weight gain, thymus weights, or plasma corticosterone levels. Relative binding potencies for cytosolic HTC glucocorticoid receptors were 1.0, 20.1, 5.4, and 2.5 for HC, P, FP16CM, and FP16CMAc, respectively. As predicted by the antedrug concept, FP16CM and FP16CMAc were very weak agonists for induction of TAT in HTC cells. Collectively, results of these investigations suggest that modification of P, which included addition of the 9-fluoro and 16-methoxycarbonyl group alone or in conjunction with a 21-acetoxy moiety, increase topical anti-inflammatory activity without significant adverse systemic effects. These new antedrugs may be useful as anti-inflammatory steroids for local applications.

Published
1997

Catalog

Books, media, physical & digital resources
See catalog results